Covidien plc (COV) Announces Launch of Therapeutic Device for Treatment of Resistant Hypertension  
1/16/2013 9:27:32 AM

MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products, today announced the commercial launch of the OneShotâ„¢ Renal Denervation System, an over the wire balloon-based irrigated catheter technology for the treatment of high blood pressure or hypertension.